CCMINC
TEVA icon

Cardinal Capital Management Inc (North Carolina)’s Teva Pharmaceuticals TEVA Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-57,624
Closed -$2.65M – 119
2016
Q3 		$2.65M Buy
57,624
+2,418
+4% +$126K 1.04% 43
2016
Q2 		$2.77M Buy
55,206
+1,323
+2% +$70.4K 1.13% 40
2016
Q1 		$2.88M Buy
53,883
+2,462
+5% +$144K 1.21% 39
2015
Q4 		$3.38M Sell
51,421
-533
-1% -$32.9K 1.51% 28
2015
Q3 		$2.93M Buy
51,954
+151
+0.3% +$9.79K 1.37% 37
2015
Q2 		$3.06M Buy
51,803
+5,358
+12% +$331K 1.34% 37
2015
Q1 		$2.89M Buy
46,445
+1,769
+4% +$103K 1.22% 42
2014
Q4 		$2.57M Buy
44,676
+2,152
+5% +$120K 1.18% 44
2014
Q3 		$2.29M Buy
42,524
+2,170
+5% +$115K 1.09% 46
2014
Q2 		$2.12M Buy
40,354
+3,850
+11% +$197K 1.05% 44
2014
Q1 		$1.93M Buy
36,504
+2,341
+7% +$108K 0.99% 46
2013
Q4 		$1.37M Buy
34,163
+1,171
+4% +$46.1K 0.7% 50
2013
Q3 		$1.25M Buy
32,992
+9
+0% +$351 0.71% 51
2013
Q2 		$1.29M Buy
+32,983
New +$1.28M 0.77% 51

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s TEVA Position: Q4 2016 in Review

Cardinal Capital Management Inc (North Carolina) sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 57,624 shares — an estimated $2.65M sold.

Cardinal Capital Management Inc (North Carolina) first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $3.38M in Q4 2015. 738 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • Cardinal Capital Management Inc (North Carolina) reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Cardinal Capital Management Inc (North Carolina) sold 57,624 Teva Pharmaceuticals shares in Q4 2016, an estimated $2.65M.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Cardinal Capital Management Inc (North Carolina)'s Teva Pharmaceuticals position peaked at $3.38M in Q4 2015.
  • 738 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q4 2016, filed 23 Jan 2017.